Nav: Home

NIH funds center for diabetes translation research led by Albert Einstein College of Medicine

December 08, 2016

Dec. 8, 2016 -- (BRONX, NY) --The National Institutes of Health has awarded researchers at Albert Einstein College of Medicine and Montefiore Health System a five-year, $2.9-million grant to launch a new center, one of only 8 in the country, for diabetes translation research. The center -- the New York Regional Center for Diabetes Translation Research (NY Regional CDTR)--also includes faculty from the Icahn School of Medicine at Mt. Sinai and the New York Academy of Medicine and will serve as a collaborative hub for investigators conducting studies on pre-diabetes, diabetes and its complications.

The two principal investigators on the grant are Elizabeth A. Walker, Ph.D., R.N., professor of medicine and of epidemiology & population health at Einstein, and Judith Wylie-Rosett, Ed.D., R.D. professor and division head of health promotion and nutrition research in the department of epidemiology & population health, and Atran Foundation Chair in Social Medicine at Einstein.

"Our overall goal is to improve the health of people who have diabetes or are at risk for developing it, with a focus on low-income communities and various racial and ethnic groups that are disproportionately affected by the disease and poor access to care," says Dr. Wylie-Rosett. "Einstein and Montefiore have a long-standing commitment to social justice, and this center provides a way for us to share our research expertise with others trying to reduce health disparities and promote health equity."

Members of certain ethnic and racial groups -- including Latinos/Hispanics, African-Americans and Asian-Americans -- face a higher risk for developing diabetes than do non-Latino white adults. They are also at increased risk for diabetes-related complications, such as lower limb amputations, vision loss and kidney failure. In addition, diabetes is 70 percent more common in high-poverty neighborhoods than in more affluent ones. This regional research center will concentrate on improving diabetes prevention, care and diabetes self-management education among these groups through research activities.

"Our center will support and promote collaborative, innovative programs of research to tailor diabetes interventions for different ethnicities and age groups and to reduce obesity, a major risk factor for diabetes, and make the best use of electronic medical records and telecommunication -- efforts aimed at prevention of diabetes and its complications," says Dr. Walker.

"We are particularly excited that the center will include the newly-created Latino Network for Diabetes Translation Research, a joint effort with investigators from the NIH-funded Hispanic Community Health Study (HCHS)/Study of Latinos (SOL)," adds Dr. Walker.

Consultative resources within the NY Regional CDTR will support diabetes prevention and control research: across the lifespan; in population health and health systems; and for intervention research methods including biological, behavioral, psychological and social factors. Other key Einstein-Montefiore faculty leaders include: associate center directors Carmen Isasi, M.D., Ph.D. and Jeffrey S. Gonzalez, Ph.D. and co-investigators Carol Derby, Ph.D., M. Diane McKee, M.D., M.S. and Urvashi Patel, Ph.D., M.P.H..
-end-
The new center's multidisciplinary members include 77 investigators doing research in diabetes prevention and control from 16 institutions including: Columbia University; Weill Cornell Medical College; Drexel University; University of Massachusetts Medical School at Worcester; New York University; Penn State University; San Diego State University; Scripps Whittier Diabetes Institute; Stanford University; Tufts University; University of California at Irvine; and University of Illinois at Chicago.

The grant is titled "The New York Regional Center for Diabetes Translation Research" (P30DK111022).

About Albert Einstein College of Medicine

Albert Einstein College of Medicine is one of the nation's premier centers for research, medical education and clinical investigation. During the 2016-2017 academic year, Einstein is home to 717 M.D. students, 166 Ph.D. students, 103 students in the combined M.D./Ph.D. program, and 278 postdoctoral research fellows. The College of Medicine has more than 1,900 full-time faculty members located on the main campus and at its clinical affiliates. In 2016, Einstein received more than $160 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centers)at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore Medical Center, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit http://www.einstein.yu.edu/, read our blog, follow us on Twitter, like us on Facebook and view us on YouTube.

About Montefiore Health System

Montefiore Health System is one of New York's premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 10 hospitals, including the Children's Hospital at Montefiore, Burke Rehabilitation Hospital and close to 200 outpatient care sites. The advanced clinical and translational research at its' medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its' preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information please visit http://www.montefiore.org/. Follow us on Twitter and view us on Facebook and YouTube.

Albert Einstein College of Medicine

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
More Diabetes News and Diabetes Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.